Insider · CIK 0002001910
Alexander Hardy
ceoofficerdirector
Files at BMRN (BIOMARIN PHARMACEUTICAL INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +375 | $54.14 | $20k | 175,958 | Dec 2, 2025 |
| Dec 1, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -16,570 | $55.03 | $912k | 159,388 | Dec 2, 2025 |
| Mar 14, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -2,933 | $69.44 | $204k | 131,223 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +44,360 | $0.00 | $0 | 175,583 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +61,750 | $0.00 | $0 | 61,750 | Mar 18, 2025 |
| Oct 31, 2024 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +300 | $56.01 | $17k | 148,451 | Dec 3, 2024 |
| Nov 29, 2024 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -14,295 | $66.03 | $944k | 134,156 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.